Neurology · 1995 · 41 citations · 0 references
MedicinePharmacologyPharmacotherapyEpilepsyHepatic PharmacotherapyNeuropharmacologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyGabaergic PharmacologyHepatic EncephalopathyLiver DiseaseSeizure ManagementAcute Intermittent PorphyriaAntiepileptic Gabaergic AgentsBenzodiazepine Treatment
Most antiepileptic drugs (AEDs) available have demonstrated porphyrogenicity in hepatic porphyrias. Gabapentin is a new AED not appreciably metabolized by the liver in humans. We report two patients with acute intermittent porphyria successfully treated with gabapentin without its inducing porphyric crisis.